231 related articles for article (PubMed ID: 7058967)
1. The interaction of cigarette smoking, oral contraceptive use, and cardiovascular risk factor variables in children: the Bogalusa Heart Study.
Webber LS; Hunter SM; Baugh JG; Srinivasan SR; Sklov MC; Berenson GS
Am J Public Health; 1982 Mar; 72(3):266-74. PubMed ID: 7058967
[TBL] [Abstract][Full Text] [Related]
2. Associations of oral contraceptive use with serum lipids and lipoproteins in young women: the Bogalusa Heart Study.
Greenlund KJ; Webber LS; Srinivasan S; Wattigney W; Johnson C; Berenson GS
Ann Epidemiol; 1997 Nov; 7(8):561-7. PubMed ID: 9408552
[TBL] [Abstract][Full Text] [Related]
3. Adverse influences of alcohol, tobacco, and oral contraceptive use on cardiovascular risk factors during transition to adulthood.
Croft JB; Freedman DS; Cresanta JL; Srinivasan SR; Burke GL; Hunter SM; Webber LS; Smoak CG; Berenson GS
Am J Epidemiol; 1987 Aug; 126(2):202-13. PubMed ID: 3605049
[TBL] [Abstract][Full Text] [Related]
4. Cigarette smoking and oral contraceptive use influence women's lipid, lipoprotein, and cardiovascular responses during stress.
Davis MC; Matthews KA
Health Psychol; 1990; 9(6):717-36. PubMed ID: 2286182
[TBL] [Abstract][Full Text] [Related]
5. Transitions of cardiovascular risk from adolescence to young adulthood--the Bogalusa Heart Study: I. Effects of alterations in lifestyle.
Croft JB; Foster TA; Parker FC; Cresanta JL; Hunter SM; Webber LS; Srinivasan SR; Berenson GS
J Chronic Dis; 1986; 39(2):81-90. PubMed ID: 3944230
[TBL] [Abstract][Full Text] [Related]
6. The interactions of body weight, age, cigarette smoking and hormone usage with blood pressure and plasma lipids in an Australian community.
Simons LA; Simons J; Jones AS
Aust N Z J Med; 1984 Jun; 14(3):215-21. PubMed ID: 6594111
[TBL] [Abstract][Full Text] [Related]
7. Cigarette smoking initiation and longitudinal changes in serum lipids and lipoproteins in early adulthood: the Bogalusa Heart Study.
Freedman DS; Srinivasan SR; Shear CL; Hunter SM; Croft JB; Webber LS; Berenson GS
Am J Epidemiol; 1986 Aug; 124(2):207-19. PubMed ID: 3728437
[TBL] [Abstract][Full Text] [Related]
8. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids.
Kakis G; Powell M; Marshall A; Woutersz TB; Steiner G
Int J Fertil Menopausal Stud; 1994; 39(5):283-91. PubMed ID: 7820162
[TBL] [Abstract][Full Text] [Related]
9. Oral contraceptive use and hemodynamic, lipid, and fibrinogen responses to smoking and stress in women.
Davis MC
Health Psychol; 1999 Mar; 18(2):122-30. PubMed ID: 10194047
[TBL] [Abstract][Full Text] [Related]
10. Cardiovascular disease: pathogenesis, epidemiology, and risk among users of oral contraceptives who smoke.
Castelli WP
Am J Obstet Gynecol; 1999 Jun; 180(6 Pt 2):S349-56. PubMed ID: 10368520
[TBL] [Abstract][Full Text] [Related]
11. Race and gender differences in serum lipoproteins of children, adolescents, and young adults--emergence of an adverse lipoprotein pattern in white males: the Bogalusa Heart Study.
Srinivasan SR; Wattigney W; Webber LS; Berenson GS
Prev Med; 1991 Nov; 20(6):671-84. PubMed ID: 1766940
[TBL] [Abstract][Full Text] [Related]
12. The effect of low-dose oral contraceptives on cardiorespiratory function, coagulation, and lipids in exercising young women: a preliminary report.
Notelovitz M; Zauner C; McKenzie L; Suggs Y; Fields C; Kitchens C
Am J Obstet Gynecol; 1987 Mar; 156(3):591-8. PubMed ID: 3826206
[TBL] [Abstract][Full Text] [Related]
13. Lipids and cardiovascular disease: do the findings and therapy apply equally to men and women?
LaRosa JC
Womens Health Issues; 1992; 2(2):102-11; discussion 111-3. PubMed ID: 1617306
[TBL] [Abstract][Full Text] [Related]
14. Fasting plasma lipids, lipoproteins and apolipoproteins in Nigerian women using combined oral and progestin-only injectable contraceptives.
Oyelola OO
Contraception; 1993 May; 47(5):445-54. PubMed ID: 8513671
[TBL] [Abstract][Full Text] [Related]
15. Oral contraceptive use and coronary risk factors in women.
Leaf DA; Bland D; Schaad D; Neighbor WE; Scott CS
Am J Med Sci; 1991 Jun; 301(6):365-8. PubMed ID: 2039021
[TBL] [Abstract][Full Text] [Related]
16. Progestins and oral contraceptive-induced lipoprotein changes: a prospective study.
Lipson A; Stoy DB; LaRosa JC; Muesing RA; Cleary PA; Miller VT; Gilbert PR; Stadel B
Contraception; 1986 Aug; 34(2):121-34. PubMed ID: 3096633
[TBL] [Abstract][Full Text] [Related]
17. Effects of smoking on prostacyclin formation and platelet aggregation in users of oral contraceptives.
Roy S
Am J Obstet Gynecol; 1999 Jun; 180(6 Pt 2):S364-8. PubMed ID: 10368522
[TBL] [Abstract][Full Text] [Related]
18. Estimates of the risk of cardiovascular death attributable to low-dose oral contraceptives in the United States.
Schwingl PJ; Ory HW; Visness CM
Am J Obstet Gynecol; 1999 Jan; 180(1 Pt 1):241-9. PubMed ID: 9914611
[TBL] [Abstract][Full Text] [Related]
19. Cardiovascular and mood responses to quantified doses of cigarette smoke in oral contraceptive users and nonusers.
Masson CL; Gilbert DG
J Behav Med; 1999 Dec; 22(6):589-604. PubMed ID: 10650538
[TBL] [Abstract][Full Text] [Related]
20. Lipids, cardiovascular disease, and oral contraceptives: a practical perspective.
Upton GV
Fertil Steril; 1990 Jan; 53(1):1-12. PubMed ID: 2403935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
